Page last updated: 2024-08-17

bromodeoxyuridine and ap20187

bromodeoxyuridine has been researched along with ap20187 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clayton, B; Fenstermaker, AG; Harding, HP; Jamison, S; Li, J; Lin, W; Lin, Y; Popko, B; Ron, D; Way, SW1

Other Studies

1 other study(ies) available for bromodeoxyuridine and ap20187

ArticleYear
Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Apr-03, Volume: 33, Issue:14

    Topics: Age Factors; Animals; Animals, Newborn; Brain; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Cytokines; Disease Models, Animal; eIF-2 Kinase; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Immunosuppressive Agents; In Situ Nick-End Labeling; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Myelin Basic Protein; Myelin Proteolipid Protein; Neutrophil Infiltration; Oligodendroglia; Protein Phosphatase 1; Receptor Protein-Tyrosine Kinases; RNA, Messenger; Signal Transduction; Stem Cells; T-Lymphocytes; Tacrolimus; Time Factors; Transcription Factor CHOP

2013